• Panlor.com
    Product website
  • Dihydrocodeine Study
    Pamlab, L.L.C. recently conducted an efficacy study to compare the analgesic relief provided by a hydrocodone combination product and our Panlor® SS product. This abstract provides an overview of those results.
  • Types of pain
    More information about the nature of pain and the various different types of pain experienced by patients.

Basic Information on Pain
Pain is a symptom. Pain is an uncomfortable experience with a variety of causes that usually signals an underlying disorder. As such, pain is usually the first sign of a problem that leads patients to visit their doctors. As a symptom, pain provides the doctor with critical information in determining a diagnosis for the true underlying problem.

Pain is Common:

  • More than 40 million Americans suffer from pain ranging from chronic, recurring headaches to back problems
  • Arthritis affects nearly 20 million Americans.
  • 15% of American adults suffer some degree of back pain during their lives
  • 4 in 10 Americans report suffering pain on a daily basis.
  • 5 in 10 Americans report that pain interferes with their sleep.
  • 58% of Americans report that over-the-counter pain medication is not completely effective for their pain
  • 80% of all U.S. doctor visits are for conditions with pain.

Panlor® SS and Panlor® DC are indicated for the relief of moderate to moderately severe pain. More information is provided at the Panlor® website.

Panlor® is indicated for the analgesic relief of moderate to moderately severe pain. Each dose contains an effective triad formula of dihydrocodeine, acetaminophen and caffeine.

More from our Product Family
  • Cerefolin®NAC: for the dietary management of hyperhomocysteinemia; particularly for individuals diagnosed with or at risk for mild to moderate cognitive impairment, vascular dementia, or Alzheimer's disease.
  • Diatx®Zn is a medical food indicated for the distinct nutritional requirements of patients under a physician's treatment for hyperhomocysteinemia with particular emphasis for those individuals diagnosed with chronic kidney disease (CKD), end stage renal disease (ESRD) or dialysis.